U.S. MMJ market to quadruple in size over the next five years, predict analysts

Neutra Corp. (OTCBB: NTRR), a provider of all-natural wellness solutions, welcoms a new law passed in Nevada last week allowing medical marijuana (MMJ) patients to obtain their medicine from dispensaries at last. As more states rush to join them, many analysts predict that the $1.7 billion U.S. MMJ market will quadruple in size over the next five years.

“We plan to have NTRR well-positioned to capture a piece of the incredible growth that's already beginning.”

That's good news for NTRR. As the company works to deliver new MMJ innovations to patients in need, the market for those innovations is growing larger every day. Nevada becomes the 14^th state to legalize medical marijuana dispensaries, and it's one of 19 states plus the District of Columbia where medical marijuana is now available.

"As voters and state legislators across the U.S. come together to end the prohibition on medicinal cannabis, the demand for new and effective MMJ treatments and technologies will skyrocket," said NTRR CEO Sydney Jim. "We plan to have NTRR well-positioned to capture a piece of the incredible growth that's already beginning."

NTRR continues to target potential industry partnerships in order to achieve its aggressive expansion goals for 2013. Last week, the company announced that it has signed a letter of intent with Vertigo Technologies, LLC, to help deliver new innovations that could slash the time and work required to prepare medicinal cannabis for dispensary shelves.

By providing innovative products and services related to MMJ, Neutra Corp. plans to follow in the footsteps of other successful public companies, including Cannabis Science, Inc. (CBIS), Medical Marijuana Inc. (MJNA) and Terra Tech Corp. (TRTC), enabling technological advancements in the cultivation and processing of cannabis in approved markets.